Using bioelectrohydrogenesis left-over residues as a future potential fertilizer for soil amendment.

In this current research, the left-over residues collected from the dark fermentation-microbial electrolysis cells (DF-MEC) integrated system solely biocatalyzed by activated sludge during the bioconversion of the agricultural straw wastes into hydrogen energy, was investigated for its feasibility to be used as a potential alternative biofertilizer to the commonly costly inorganic ones. The results revealed that the electrohydrogenesis left-over residues enriched various plant growth-promoting microbial communities including Enterobacter (8.57%), Paenibacillus (1.18%), Mycobacterium (0.77%), Pseudomonas (0.65%), Bradyrhizobium (0.12%), Azospirillum (0.11%), and Mesorhizobium (0.1%) that are generally known for their ability to produce different essential phytohormones such as indole-3-acetic acid/indole acetic acid (IAA) and Gibberellins for plant growth. Moreover, they also contain both phosphate-solubilizing and nitrogen-fixing microbial communities that remarkably provide an adequate amount of assimilable phosphorus and nitrogen required for enhanced plants or crop growth. Furthermore, macro-, and micronutrients (including N, P, K, etc.) were all analyzed from the residues and detected adequate appreciate concentrations required for plant growth promotions. The direct application of MEC-effluent as fertilizer in this current study conspicuously promoted plant growth (Solanum lycopersicum L. (tomato), Capsicum annuum L. (chilli), and Solanum melongena L. (brinjal)) and speeded up flowering and fruit-generating processes. Based on these findings, electrohydrogenesis residues could undoubtedly be considered as a potential biofertilizer. Thus, this technology provides a new approach to agricultural residue control and concomitantly provides a sustainable, cheap, and eco-friendly biofertilizer that could replace the chemical costly fertilizers.

Chemical investigation and anti-inflammatory activities of the aerial part of Filipendula palmata.

ETHNOPHARMACOLOGICAL RELEVANCE: Filipendula palmata Maxim. as an ethnic herb is commonly used by Oroqen minority people in the treatment of rheumatism in China and as a wild vegetable is eaten by Russian in the Far East area. However, so far, the chemical constituents and bioactivity of this edible herb are still unclear, especially the anti-inflammatory constituents and action have not been elucidated despite the traditional folk use. AIM OF STUDY: The current study was conducted to investigate the main chemical components of the aerial part of F. palmata and evaluate the anti-inflammatory and antioxidant and cytotoxic activities of the extract and the isolated constituents. MATERIALS AND METHODS: Various chromatographic techniques including silica gel, ODS, HPLC were used to isolate the components and several spectroscopic methods such as UV, IR, MS and NMR were adopted to characterize the structures of the compounds. The inhibitory action of the extract and components on the production of nitric oxide stimulated by LPS in RAW264.7 cells was applied to evaluate the anti-inflammatory activity and the MTT method was used to investigate the cytotoxicity. In addition, the antioxidant capacity of F. palmata was measured in three in vitro assays including DPPH and hydroxyl radicals scavenging and FRAP experiments. RESULTS: The bioactivity research demonstrated that the EtOAc fraction and n-BuOH fraction of this ethnic herb possessed potent anti-inflammation activity in RAW264.7 macrophages and antioxidant activity in three in vitro assays. The chemical study on the EtOAc fraction led to a new dihydrophenanthrene derivative, filipendutin A (1), together with 9 known compounds from the herb, in which compound 4 could significantly inhibit the production of nitric oxide in RAW264.7 cells, while compounds 1 and 9 exhibited obvious cytotoxicity in cells. CONCLUSIONS: These results demonstrated that F. palmata had significant anti-inflammatory and antioxidant activities and could be used in the treatment of inflammatory diseases. Meanwhile, the cytotoxic activity of EtOAc fraction and its components also indicated the potential application in antitumor which remained the further study in the future.

A new coumarin isolated from the roots of Heracleum dissectum Ledeb.

A new coumarin named (9 R, 10 R)-9, 10-dihydro-10-hydroxy-9-methoxy-bergapten (1) and 13 known compounds (2-14) were isolated from the roots of Heracleum dissectum Ledeb., in which compounds (2-13) were obtained from H. dissectum for the first time. Their structures were illuminated by HR-ESI MS, 1 D and 2 D NMR, optical rotation and comparison with literatures. All compounds were evaluated against hepatocellular carcinoma HepG2 cell lines and the results showed that candinol C (8) had moderate cytotoxic activity against HepG2 cells with IC50 value at 57.6 ± 1.1 µM.

Effectiveness of deep electroacupuncture with strong deqi and shallow electroacupuncture with no deqi for lumbar disk herniation: study protocol for a randomised controlled trial.

INTRODUCTION: Lumbar disk herniation (LDH) is a common cause of low back pain and dysfunction. Studies have shown that electroacupuncture (EA) can achieve pain relief in patients with LDH. However, there is a lack of evidence regarding the effectiveness of deep EA with strong deqi and shallow EA with no deqi in patients with LDH. This study aims to evaluate the effectiveness of deep EA with strong deqi and shallow EA with no deqi in the treatment of LDH. METHODS AND ANALYSIS: In this randomised controlled trial, patients with LDH who have low back pain with or without radiculopathy for at least 12 weeks will be enrolled. In total, 44 patients will be recruited from the Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China. Patients will be randomised into the deep EA group and the shallow EA group in a ratio of 1:1 and will be administered 12 sessions of EA treatment (three times a week for 4 weeks, 20 min for each session). The follow-up duration will be 4 weeks. Low back pain intensity and leg pain intensity (in patients with radicular pain) measured using the Visual Analogue Scale (VAS) will be assessed as the primary outcomes. Function (measured using the Roland-Morris Disability Questionnaire), quality of life (measured using the EuroQol Five-Dimensional Five-Level Questionnaire) and patient-evaluated therapeutic effect will be assessed as the secondary outcomes. Patients' expectations of EA, the success of the blinding method and safety will also be evaluated. Statistical analyses will be followed by the intention-to-treat analysis. ETHICS AND DISSEMINATION: This study was approved by the Ethics Committee of the Third Affiliated Hospital of Beijing University of Chinese Medicine (approval number: 2019-XS-ZB06). Study results will be disseminated through publication in an open access journal. TRIAL REGISTRATION NUMBER: ChiCTR-1900026518.